Skip to content

Study of the Psychometric Properties of Two Questionnaires for Measuring Disease Flare-up in IBD

Study of the Psychometric Properties of Two Questionnaires for Measuring Disease Flare-up in IBD (Crohn's Disease / Hemorrhagic Rectocolitis)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06214299
Acronym
Flare-IBD
Enrollment
400
Registered
2024-01-19
Start date
2024-01-31
Completion date
2024-03-31
Last updated
2024-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Inflammatory Bowel Diseases

Keywords

Psychometric properties, Patient-Reported Outcomes

Brief summary

Validating two questionnaires for measuring relapse in IBD (Crohn's / UC)

Detailed description

IBD (Chronic Inflammatory Bowel Diseases) includes Crohn's disease and ulcerative colitis (UC). In France, an estimated 300,000 people suffer from IBD (source afa Crohn RCH France). To our knowledge, there are no Patient Reported Outcomes (PROs) validated in French to measure the relapse phenomenon in IBD. Such an instrument would complement the available indicators and enable clinicians to detect treatment response at an early stage, as well as failure to respond to treatment, as manifested by the resumption or increased frequency of relapses, and thus enable rapid adjustment of the proposed therapeutic strategy. Two questionnaires have been developed, their psychometric properties need to be studied. The project's deliverable will therefore be two validated questionnaires for measuring relapse from the patient's perspective in IBD for routine use. For this reason, the questionnaires will be short, simple to use, easy to interpret and designed to integrate online applications for patient self-monitoring of IBD disease activity.

Interventions

None listed

Sponsors

EPSTEIN Jonathan
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient member of the AFA Crohn RCH, and registered in the mailing list * Person having received full information on the organization of the research and not having objected to his/her participation and to the use of his/her data.

Exclusion criteria

\- There were no non-inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Structural validity evaluated by a confirmatory factor analysis, thresholds: comparative fit index (CFI)>0.90, Tucker-Lewis index (TLI)>0.90, root mean square error of approximation (RMSEA)<0.08day 0Psychometric properties measurable in a cross-sectional study as described by the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN), using classical test theory and item response theory

Secondary

MeasureTime frameDescription
Reproducibility evaluated by answers to respondents' questions according to declared status corresponding to current absence of relapse. Measured by intraclass correlation coefficient (ICC), a value above 0.70 is expected for acceptable reproducibilityday 15Reproductibility

Contacts

Primary ContactANDREIA CARVALHO DE FREITAS
a.carvalhodefreitas@chru-nancy.fr0383859305

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026